PLAB 2 Prescribing Safety & Emergency Management 2

Question 1

A 35-year-old woman has a blood pressure of 180/115 on booking at 8 weeks gestation. She has no proteinuria. What is the most likely diagnosis and first-line antihypertensive?

Accepted Answer

Chronic hypertension (pre-existing, presenting before 20 weeks) — first-line antihypertensives in pregnancy are labetalol, nifedipine, or methyldopa

Answer

Hypertension before 20 weeks (or pre-pregnancy) is chronic hypertension. Pre-eclampsia presents after 20 weeks. Safe antihypertensives in pregnancy: labetalol (first-line for chronic hypertension), nifedipine (second line), methyldopa (safe but side effects). ACE inhibitors and ARBs are contraindicated in pregnancy.

Question 2

A patient presents with a blood glucose of 28 mmol/L, bicarbonate of 10 mmol/L, pH 7.15, blood ketones of 4.8 mmol/L, and is vomiting. What is the diagnosis and initial management?

Accepted Answer

Diabetic ketoacidosis (DKA) — IV fluids (0.9% NaCl), insulin infusion (0.1 unit/kg/hr), potassium replacement, monitoring, and treat precipitant

Answer

DKA: hyperglycaemia (>11 mmol/L or known diabetes), ketonaemia (≥3 mmol/L blood ketones), acidosis (pH <7.3 or HCO3 <15). Management (JBDS guidelines): IV 0.9% NaCl resuscitation; fixed-rate IV insulin infusion 0.1 unit/kg/hr; potassium replacement (if K+ <5.5 mmol/L); glucose monitoring hourly; seek and treat precipitant; consider VTE prophylaxis.

Question 3

A junior doctor is about to prescribe trimethoprim for a UTI in a patient already taking phenytoin. What is the key drug interaction?

Accepted Answer

Trimethoprim inhibits renal tubular secretion of creatinine (raising measured creatinine without affecting actual GFR) — this is not a true drug interaction with phenytoin but trimethoprim can increase phenytoin levels by inhibiting metabolism

Answer

Trimethoprim can inhibit CYP2C9/CYP2C19, increasing phenytoin plasma levels and risking phenytoin toxicity (ataxia, nystagmus, confusion). In addition, trimethoprim artificially elevates serum creatinine (without true GFR change) by competing with creatinine for tubular secretion. Monitor phenytoin levels and for signs of toxicity.

Question 4

In the prescribing safety assessment context, which of the following is an example of a 'never event' in medication?

Accepted Answer

Administering 10 times the intended dose of IV potassium chloride (concentrated KCl) causing cardiac arrest

Answer

'Never events' are serious, wholly preventable patient safety incidents. Medication never events include: IV administration of concentrated potassium chloride; wrong route administration (e.g., intrathecal vincristine); misidentification of patients during medication administration; and insulin pump overdose. Policies require concentrated KCl to be stored and prepared by pharmacy, never on wards.

Question 5

A patient is prescribed gentamicin for a urinary tract infection with sepsis. After the third dose, serum creatinine has risen from 80 to 140 µmol/L. What should you do?

Accepted Answer

Stop gentamicin, reassess the patient, consider an alternative antibiotic, and monitor renal function — rising creatinine indicates nephrotoxicity

Answer

Rising creatinine in a patient on gentamicin indicates acute kidney injury, likely aminoglycoside nephrotoxicity (tubular toxicity). Gentamicin should be stopped, the patient reassessed clinically, renal function monitored, and an alternative antibiotic prescribed if required. Pre- and post-dose levels should be checked throughout treatment to prevent toxicity.

PLAB 2 Practice Test

PLAB 2 Practice Test

PLAB 2 Prescribing Safety & Emergency Management 2